Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation

28 Jan 2023

Abstract excerpt

Liver hepatocellular carcinoma (LIHC) is one of the main cancers worldwide and has high morbidity and mortality rates. Although previous studies have shown that ANXA10 is expressed at low levels in LIHC tumor tissues, the biological function of ANXA10 in LIHC is still unclear. Therefore, we utilized TCGA, TIMER, GEPIA2, TISIDB, LinkedOmics, ssGSEA algorithms and CIBERSORT methodology to preliminarily evaluate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36709331
DOI: 10.1038/s41598-023-28527-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validationPMID 36709331Read ↗

Development of an immune-related prognostic index associated with hepatocellular carcinomaSemantic proximity Read ↗

ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular CarcinomaSemantic proximity Read ↗

A novel model of anoikis-related gene for predicting prognosis and assessing immune status with hepatocellular carcinomaSemantic proximity Read ↗

An Anoikis-related LncRNA Signature: Integrated Analysis of Immune Infiltration Landscape in Patients with Liver Hepatocellular Carcinoma and ImmunotherapySemantic proximity Read ↗

Construction of a prognostic model and identification of key genes in liver hepatocellular carcinoma based on multi-omics dataSemantic proximity Read ↗

A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

A signature based on neutrophil extracellular trap-related genes for the assessment of prognosis, immunoinfiltration, mutation and therapeutic response in hepatocellular carcinoma.Semantic proximity Read ↗

Identification of Anoikis-Related Prognostic Genes and Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Single-Cell and Bulk Transcriptomic AnalysisSemantic proximity Read ↗

Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysisSemantic proximity Read ↗

Anoikis-related gene signature predict the prognosis and immune infiltration characterization of lung adenocarcinomaSemantic proximity Read ↗

Exploration of Signature Genes and Their Correlation with Immune Cell Infiltration in CirrhosisSemantic proximity Read ↗

A novel five‐gene signature predicts overall survival of patients with hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.